PCHi 2026: Huiwen Biology targets high-efficacy demand with PDRN innovation
09 Apr 2026 | Huiwen Biology
On the show floor of PCHi, Kayco Mou, global operations international business manager at Huiwen Biology, discussed the global launch of the company's new PDRN ingredient, highlighting PDRN's growing popularity in cosmetics. She pointed to a major shift in China’s beauty market, where consumer demand for novel, high-efficacy products has fuelled the rise of local indie brands over traditionally dominant international players. In response, Huiwen is focusing on advanced technologies to enhance ingredient performance, alongside a strong emphasis on quality and clinical evidence as consumers become increasingly discerning.
